By Priscila Mayumi Kashiwabara

Last Friday, September 9th, the Brazilian FDA (ANVISA) published and made available new subject codes for submitting requests related to the Good … New subject codes for filing applications for GMP certification for biological products industries

Check out the article “Cannabis and IP: Nurturing innovation in Brazil’s life sciences industry”, authored by Priscila Kashiwabara and Luan Scalzitti and … Cannabis and IP: Nurturing innovation in Brazil’s Life Sciences industry

It is with great honor that we share our ranking in the IAM Patent 1000 2023. In addition to being recognized as … Kasznar Leonardos was ranked on IAM Patent 1000

On May 9, 2023, the BPTO released the INPI/CPAPD technical opinion No. 01/2023, which provides guidance on the patentability of inventions related … The Brazilian PTO published a new technical opinion regarding the patentability of inventions related to transgenic plants

Patents to new medicines usually protect the active ingredient (compound), provided that it is new and inventive. It is also a common … “Brazil: The patent combination conundrum” for LSIPR Magazine

Our partners Priscila Kashiwabara and Viviane Trojan are set to attend BIO Europe Spring, which will be taking place from March 20-22, … Kasznar Leonardos will be at BIO Europe Spring

Our partner Priscila Kashiwabara and specialists Breno Alves and Gabriel Cavalcante published the article “Sustainable agriculture, green technologies and IP in Brazil” in the Global Patent Prosecution Guide … Sustainable agriculture, green technologies and IP in Brazil

Our partner and head of Life Sciences, Priscila Kashiwabara discusses plant variety protection in Brazil and its recent developments regarding legal framework for Plant … Protecting Plant Varieties in Brazil for FloraCulture Magazine

On 7 June 2022, in the Official Gazette 2683, the Brazilian patent office published a communication regarding the new standard for submission … INPI publishes communication on new sequence listing standard for patent applications in Brazil

On March 17, 2022, the BPTO released the INPI/CPAPD technical note No. 01/2022, which provides guidance on the patentability of inventions involving … Brazilian PTOs publishes a technical note providing guidance on the patentability of elite events

Patents are critical to the life sciences industry and often spark intense and heated debate. To be successful, one key strategy that … Life sciences patent eligibility in Latin America: a guide

On February 8th, 2022, the Brazilian Patent Office reported the decision to apostille letters-patent when the patent protects subject-matter going beyond the … News on apostille of letters-patent retroactively affected by the Direct Plea of Unconstitutionality 5,529

On December 28, 2021, the BRPTO published, by means of the Official Gazette nº 2660, the Ordinance #56/2021, which establishes the procedures … Sequence listing in ST.26 format is officially postponed until July 1, 2022 by the Brazilian PTO

Our partners Anderson Ribeiro, Aline Ferreira and Priscila Kashiwabara authored the chapter "Personalised medicine in Brazil: IP and regulatory challenges". This article first … Personalised medicine in Brazil: IP and regulatory challenges

Continuing with the goal of reducing the number of patent applications pending decision, the Brazilian PTO (“BPTO”) published the Ordinance/INPI/PR N° 21, … Brazilian PTO extends the Patent Backlog Fighting Project